MAPDA

Aleve® Speaks The Painful Truth, Encouraging Consumers to Explore Their Pain Management Options

Retrieved on: 
Monday, March 25, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240325938118/en/
    Aleve launches "The Painful Truth" campaign with Mothers Against Prescription Drug Abuse (MAPDA) and National Consumers League (NCL).
  • (Photo: Business Wire)
    While opioid dispensing rates in the U.S. are slowly ticking down, they remain elevated compared with rates in other countries.
  • “The Painful Truth” campaign launches with a three-minute film featuring real pain sufferers who are at crossroads in their pain relief journeys and seeking guidance.
  • At this critical juncture in their care, the patients are encouraged to consider different pain relief options.

XOMAD Sweeps Ad Age 2023 Social Media Campaign of the Year Awards

Retrieved on: 
Thursday, November 30, 2023

MANHATTAN BEACH, Calif., Nov. 30, 2023 /PRNewswire/ -- XOMAD, a marketing, communications and research company that specializes in mobilizing local social media messengers (influencers), won big at this year's Ad Age Healthcare Marketing Impact Awards, earning a clean sweep of the Gold, Silver and Bronze medals in the "Social Media Campaign of the Year" category.

Key Points: 
  • MANHATTAN BEACH, Calif., Nov. 30, 2023 /PRNewswire/ -- XOMAD, a marketing, communications and research company that specializes in mobilizing local social media messengers (influencers), won big at this year's Ad Age Healthcare Marketing Impact Awards, earning a clean sweep of the Gold, Silver and Bronze medals in the "Social Media Campaign of the Year" category.
  • XOMAD, an Influencer Marketing Company, Sweeps Ad Age 2023 Social Media Campaign of the Year Awards.
  • It's hard to win one Social Media Campaign of the Year award from Ad Age, let alone clean sweep all three.
  • XOMAD offers a breakthrough technology: a way to identify and deploy huge communities of trusted people on social media to convey a message.